NASDAQ
Chemomab Therapeutics Ltd. (CMMB) has a current ratio of 9.08x as of Monday, May 25, 2026. This represents a 7.18% decrease compared to its 12-month average of 9.79x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.